Hi there- I noticed you recently reviewed our compare products page. I want to reach out and see if you have any questions I could help answer. Can I make a suggestion? Many of our investors find success with MarketBeat All Access, and I’m willing to give you the opportunity to try it free for 30 days.
MarketBeat All Access is our premier research platform that includes MarketBeat Daily Premium, My MarketBeat, our suite of web-based research tools, and our premium research reports. With MarketBeat All Access, you will receive our real-time news feed and access to our database of more than 1,000,000 stock ratings and our proprietary brokerage rankings. You will also receive other exclusive benefits, including premium support, extended data export tools, and priority delivery of your morning newsletter. After your 30-day trial, if you are happy with the features and wish to continue your subscription, we will give you a $50.00 credit toward your MarketBeat All Access subscription. If you are interested in registering for MarketBeat All Access at the discounted rate, do it now by clicking the link below. Start My Free Trial to MarketBeat All Access. I’ll be honest, this is a really great deal, especially for the value that MarketBeat All Access offers. But don’t just take my word for it; trust what our satisfied subscribers have to say: "I use MarketBeat.com every day that the market is open to provide me with the most up-to-date financial data allowing me to support my investing decisions. There are multiple ways that you can use this resource, including the ability to personalize areas of interest and specific stock lists. I have tested several financial service companies, and this one is the best by far" - Ronald S. "MarketBeat offers an astute analysis of stocks and how they relate to the market as a whole. Their reports are concise and to the point. MarketBeat stands out as highly ethical, subjecting stocks and the broader market to the cold hard light of meticulous research. This allows me a high degree of confidence in their recommendations." -Dorothy L. If you are still hesitant about trying out our services, let me assure you there is no risk. You have nothing to lose but everything to gain. If after your 30-day trial you decide this service isn’t for you, simply cancel, and we won’t charge you. Upgrade to MarketBeat All Access Hope to hear from you soon! Matthew Paulson
MarketBeat P.S. If you have any additional questions, simply reply to this email, and our U.S.-based Customer Service team will be happy to help you.
Additional Reading from MarketBeat Media
Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record HighsWritten by Thomas Hughes. Published: 5/15/2026. 
Key Points
- Oracle's unique position as a cross-cloud database and computing platform embedded across Alphabet, Amazon, and Microsoft networks underpins its long-term competitive advantage.
- Oracle faces three catalysts: a fiscal Q4 2026 earnings release projecting 20% revenue growth, the Oracle AI World 2026 conference in October, and accelerating RPO monetization from 2027 onward.
- Analysts rate ORCL a Moderate Buy with a 76% buy-side bias and roughly 40% upside to consensus, while institutions have shifted back to accumulation in 2026.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Oracle’s (NASDAQ: ORCL) stock is on track to set record highs and keep climbing—and not just because of AI. AI is the driving force in technology today, centered on hyperscaler capacity, and Oracle is positioned as the hyperscaler to watch. While Alphabet (NASDAQ: GOOGL), Amazon (NASDAQ: AMZN), and Microsoft (NASDAQ: MSFT) all have advantages, Oracle not only competes with them but also supplies them. All rely on Oracle’s business services, but more importantly, Oracle is the database and high-speed computing platform of choice, embedded across all three cloud networks. Oracle is ubiquitous in the cloud, found everywhere, and that matters for the long term.
When the SpaceX IPO launches, most retail investors will be locked out. The banks, funds, and insiders get in early - while everyone else waits on the sidelines.
But one small infrastructure supplier - a critical piece Musk can't scale the Colossus network without - is still trading well under institutional radar. A new briefing reveals the name and ticker at no cost. Get the SpaceX infrastructure stock name and ticker here
Cross-cloud and multi-cloud capability are essential for enterprise AI success. They democratize the cloud by enabling targeted use of specialized hardware and software, on-demand scalability, alternative pathways to bypass system bottlenecks, and compliance across industries and sovereignities. Put simply, without cross-cloud capability, enterprises are dead in the water, and Oracle is critical to making it possible. The quarterly results speak for themselves, with business underpinned by cloud, AI, and hyperscale demand that has run at an accelerating triple-digit pace over the past few quarters. Oracle’s Near-Term Catalyst: Upcoming Earnings ResultsOracle’s near-term catalyst is the upcoming fiscal Q4 2026 earnings release, scheduled for early June. The company is expected to post a solid quarter, with revenue growing 20% and earnings rising at a slightly cooler pace. The consensus forecast reflects some uncertainty, as it has held within a narrow range due to mixed revisions: about half of the analysts covering the stock raised their estimates since the prior report, while the other half lowered theirs. Investors should expect strength, if not outright outperformance, given the trends reflected in other AI-critical names. They suggest the early stages of positive feedback loops in which AI build-out and infrastructure lead to AI applications, new use cases, and increased demand for AI infrastructure. The market-moving details in the report will include cloud segment growth, hyperscaler demand, and the remaining performance obligation (RPO), which supports the long-term outlook. The company’s RPO has been growing at a triple-digit pace, topping $500 million in the prior release and tracking toward the billion-dollar mark. Oracle’s Mid-Term Catalyst: Oracle AI World 2026Oracle’s mid-term catalyst is the Oracle AI World 2026 event scheduled for October. The annual conference will highlight the firm’s accomplishments, featuring keynote addresses, product showcases, product launches, and potentially new partnerships or deals. The event sets the stage for the coming year, when longer-term catalysts are expected to gain traction. The implication is that Oracle will build on its momentum, unveiling new agentic and automation tools alongside future plans. AI demand and the outlook remain robust, as we are in the earliest stages of a decades-long upcycle in hardware, software, capabilities, and outcomes. Oracle’s Long-Term Catalyst: Monetizing the BacklogOracle’s long-term catalyst involves converting the RPO into revenue—the monetization of its backlog. As it stands, the company has taken on significant debt to build out its empire and is on track to begin monetization this year. However, the 2026 conversion will be minimal, as most of the contracted backlog is for future capacity tied to upcoming NVIDIA (NASDAQ: NVDA) Vera Rubin and Advanced Micro Devices (NASDAQ: AMD) MI450 products. What this means is that monetization will begin to gain traction in 2027, accelerate in 2028, and remain at a high pace in the years that follow. The question is how high that pace will be, and for how long. Conditions are improving in 2026, driven by solid results, outperformance, and visibly growing systemic demand for AI. Within the long-term catalyst is the expectation of significant margin improvements. Not only is AI spending expected to slow, but operational leverage is also expected to improve, driving accelerated earnings growth over time. The implication is that Oracle’s debt is only a near-term challenge, as cash flow will likely whittle it down over the coming years, setting the stage for balance-sheet improvements and capital returns. Analysts and Institutions Are Buying Into Oracle’s OutlookInstitutional profit-taking helped cap ORCL gains in late 2025, but the story changed in 2026. Institutions returned to accumulation as the stock fell, helping establish the market bottom and the April rebound. Analyst trends have been equally bullish, with price target increases resuming in 2026. Sentiment is pegged at Moderate Buy, with a 76% Buy-side bias and approximately 40% upside to the consensus target. Recent revisions, including a price target increase from Wedbush, point to the high end of the range, adding double digits to the consensus target and putting the market dangerously close to a fresh all-time high. |
No comments:
Post a Comment